Ingredients CITRIC ACID, POTASSIUM CITRATE, MALTODEXTRIN, ASPARTAME*, MAGNESIUM OXIDE, CONTAINS LESS THAN 2% OF NATURAL FLAVOR, ACESULFAME POTASSIUM, SOY LECITHIN, ARTIFICIAL COLOR, RED 40
On the same topic: Covid: vaccines and therapies available or still being reviewed Take a stock on Covid-19 vaccines and treatments across the world
Patients should be aware that: No licensed combination product exists in the UK Any combination use would be considered experimental and is not supported by current evidence Clinical decisions must be guided by a qualified healthcare professional with access to current trial data Clinical Evidence and Trial Data Available to UK Patients Retatrutide Phase 2 data showed approximately 24% mean body weight reduction at the highest dose over 48 weeks, but no published trial data exist for the specific cagrilintideretatrutide combination
Allergic Reactions : Rare cases report fevers, hives, blistering at the injection site, muscle aches, and rash following administration
